The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure

  1. Rouhi, L.
  2. Fan, S.
  3. Cheedipudi, S.M.
  4. Braza-Boïls, A.
  5. Molina, M.S.
  6. Yao, Y.
  7. Robertson, M.J.
  8. Coarfa, C.
  9. Gimeno, J.R.
  10. Molina, P.
  11. Gurha, P.
  12. Zorio, E.
  13. Marian, A.J.
Revue:
Cardiovascular research

ISSN: 1755-3245

Année de publication: 2022

Volumen: 118

Número: 6

Pages: 1466-1478

Type: Article

DOI: 10.1093/CVR/CVAB197 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus